Artificial Oocyte Activation
Conditions: Infertility; Ovarian Insufficiency Interventions: Other: women having had a second IVF cycle with AOA Sponsors: Clinique Ovo Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Primary Cytoreductive Surgery
Conditions: Ovarian Cancer; Fallopian Tube Carcinoma; Ovarian Carcinoma; Peritoneal Carcinoma; Ovarian Cancer Stage IIIC; Fallopian Tube Cancer Stage IIIC; Ovarian Cancer Stage IV; Fallopian Tube Cancer Stage IV; Fallopian Tube Cancer; Peritoneal Cancer Interventions: Biological: Acute Normovolemic Hemodilution/ANH Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
Conditions: Neoplasms; Non-small-cell Lung Cancer; Melanoma; Squamous Cell Carcinoma of the Head and Neck; Renal Cell Carcinoma; Urothelial Carcinoma; Colorectal Carcinoma; Ovarian Carcinoma Interventions: Drug: PF-07820435; Biological: Sasanlimab Sponsors: Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients
Conditions: Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer) Interventions: Drug: Allogeneic NK （CCT-ANK-11) Sponsors: Escure Biotechnology Corp; Beijing Kejing Biotechnology Corp. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration
Conditions: Mesothelioma, Malignant; Carcinoma, Non-Small-Cell Lung; Carcinoma Breast Stage IV; Ovarian Cancer; Esophageal Cancer; Gastric Cancer Interventions: Drug: Cisplatine Teva ® Sponsors: Dr Jean Yannis PERENTES Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation
Conditions: Endometrial Receptivity Interventions: Procedure: Controlled Ovarian Stimulation + Luteal Phase Support; Procedure: Hormonal Replacement Therapy programmed artificial cycle; Procedure: Natural Cycle (NC); Procedure: Endometrial receptivity reference group Sponsors: Fundaci ón IVI; Instituto Valenciano de Infertilidad, IVI VALENCIA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Conditions: Cancer-associated Thrombosis; Venous Thromboembolism; Gynecologic Cancer; Ovarian Cancer; Cervix Cancer; Endometrial Cancer; Vaginal Cancer Interventions: Drug: Anticoagulant Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione Umberto Veronesi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
Conditions: Ovarian Cancer Sponsors: Geneplus-Beijing Co. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward
Conditions: Epithelial Ovarian Cancer Interventions: Procedure: China Hyperthermic Intraperitoneal Chemotherapy(C-HIPEC) Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Shenshan Medical Center, Memorial Hospital of Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
Conditions: Ovarian Clear Cell Carcinoma Interventions: Drug: physician ' s choice of chemotherapy; Drug: immune checkpoint inhibitor based therapy Sponsors: Tongji Hospital; Wuhan Union Hospital, China; Henan Cancer Hospital; Qilu Hospital of Shandong University; Hubei Cancer Hospital; Anhui Provincial Cancer Hospital; Peking University Cancer Hospital& Institute; Hunan Province Tumor Hospital; First Affiliated Hospital of Suzhou Medical College; Shandong Tumor Hospital; Chongqing University Cancer Hospital; First Affiliated Hospital of Zhongshan Medical University; Peking University Shenzhen Hospital Not yet recruiting (...
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Phase 1, Safety and Tolerability Study of XmAb ®541 in Advanced Solid Tumors
Conditions: Ovarian Cancer; Endometrial Cancer; Germ Cell Tumor; Testicular Germ Cell Tumor; Ovarian Germ Cell Tumor Interventions: Biological: XmAb541 Sponsors: Xencor, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
Conditions: Serous Ovarian Tumor; Endometrioid Carcinoma Ovary; Fallopian Tube Cancer; Primary Peritoneal Carcinoma Interventions: Genetic: Somatic and Germline BRCA1/2 Testing Sponsors: Cancer Trials Ireland Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Tumor Microenvironment in Ovarian Cancer
Conditions: Ovarian Cancer Stage III; Ovarian Cancer Stage IV Interventions: Other: Ovarian Cancer Organoids Sponsors: University of Udine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging
Conditions: Ovarian Aging Interventions: Drug: Yijing Keli Sponsors: Tongji Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled Trial
Conditions: Fibroid Uterus Interventions: Procedure: Temporary clipping of the uterine arteries and the utero-ovarian ligmants.; Procedure: No temporary clipping of the uterine arteries and the utero-ovarian ligmants. Sponsors: Universitaire Ziekenhuizen KU Leuven; Amsterdam UMC, location VUmc; Bichat Hospital; Rennes University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
